#growth hormone

• Acromegalic — Suffering from acromegaly; characterized by the excessive and disproportionate development of the body's extremities (hands, feet, facial bones, nose, jaw) due to the pathological hypersecretion of growth hormone (somatotropin) after the closure of epiphyseal plates. As a noun, it designates a male individual clinically diagnosed with this chronic neuroendocrine condition, most commonly triggered by a pituitary adenoma.
• Acromegalic woman — The feminine form of the word 'acromegal'; it describes a female individual or an anatomical structure (conformation, physiognomy, symptomatology) affected by acromegaly or characterized by the traits of this disease. In women, the progression of the condition can cause, alongside skeletal changes, severe menstrual cycle disorders and macroglossia.
• Acromegalic — A synonymous variant of the adjective acromegal; relating to acromegaly, manifesting its symptoms, or affected by the hypersecretion of somatotropin. As a noun, the term defines a male individual presenting the clinical picture of the disease, marked by hypertrophy of the facial bones, hands, and feet secondary to a pituitary adenoma.
• Acromegalic woman — The feminine form of the word 'acromegalic'; it defines a female individual or a physical manifestation affected by this neuroendocrine dysfunction. The symptomatology in women comprises, alongside facial and skeletal changes, frequent associations with secondary hypertension and voice deepening.
• Acromegaly — A chronic neuroendocrine disease caused by a pathological hypersecretion of growth hormone (somatotropin) and insulin-like growth factor (IGF-1) in adulthood, after the closure of epiphyseal growth plates. The condition is characterized by the exaggerated enlargement of skeletal extremities (hands, feet), hypertrophy of facial bones (prognatism, prominent brow ridges), soft tissue thickening, macroglossia, and secondary severe cardiac or metabolic dysfunctions.
• Growth therapy — A medical method or therapeutic protocol focused on treating severe physical and stature development deficiencies in children and adolescents, primarily consisting of the controlled administration of growth hormone and the optimization of nutritional factors to stimulate skeletal elongation.